UROTHELIAL CARCINOMA (UC)

This study is for people with bladder cancer that has spread to a small number of other body parts (up to 3 spots). It compares standard treatment (chemotherapy or immunotherapy) alone versus standard treatment plus a precise, high-dose radiation therapy called stereotactic body …

This early-stage study tests a new drug called XL092, alone or with other immune-boosting drugs, in people with advanced solid tumors (like kidney, prostate, lung, or colon cancer) that can't be removed by surgery. The main goals are to find safe doses and see if the treatment sh…

This study is testing a new treatment that delivers radiation directly to cancer cells in people with advanced solid tumors that cannot be removed by surgery. The treatment uses a special molecule to find and attach to cancer cells, then delivers a radioactive payload to destroy …

This early-stage study is testing a new drug, IDE892, both alone and in combination with another drug called IDE397. It is for adults with advanced solid tumors that have a specific genetic change called MTAP deletion and have stopped responding to standard treatments. The main g…

This study is testing a new type of PET/CT scan that uses a special tracer called 18F-T2 to find cancers that have high levels of a protein called CAIX. About 200 adults with cancers like kidney, bladder, lung, or breast cancer will get this scan to see if it works better than th…

This study is testing whether a simple blood or urine test (called a liquid biopsy) can help find, monitor, and predict the return of urothelial carcinoma, a type of bladder cancer. Researchers will compare these test results with standard tissue biopsies in 300 people who have o…

This study follows 300 Korean adults with a type of kidney and ureter cancer to see how often the cancer comes back after treatment. Participants receive standard chemotherapy and surgery, and researchers collect blood samples and medical data over time. The goal is to build a da…